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NEONATAL ABSTINENCE SYNDROME NONPHARMACOLOGICAL
INTERVENTION EDUCATION FOR HEALTHCARE PROFESSIONALS CARING
FOR NEWBRONS

An Abstract of the Scholarly Project by
Darby Harvey

Neonatal abstinence syndrome has increased significantly in the United States
over the past few decades due to the increase of maternal substance abuse. The overall
goal of caring for these infants is effective management of the withdrawal symptoms,
including both pharmacological and nonpharmacological interventions. However,
nonpharmacological interventions have been shown to improve infant outcomes and
reduce length of hospitalization. This project sought to increase healthcare professionals’
knowledge and confidence regarding neonatal abstinence syndrome and the utilization of
nonpharmacological interventions when caring for infants diagnosed with neonatal
abstinence syndrome through the provision of an educational presentation. This study
utilized a one-group pretest-posttest design with healthcare professionals caring for
newborns in a hospital setting. Healthcare professionals were recruited via convenience
and snowball sampling through social media platforms. Participants’ knowledge and
confidence were measured before, after, and six-weeks following an educational
presentation. According to the findings, the educational presentation improved healthcare
professionals’ knowledge and confidence regarding neonatal abstinence syndrome and
the utilization of nonpharmacological interventions when caring for an infant diagnosed
with neonatal abstinence syndrome. These findings determine that education can be
beneficial for increasing healthcare professionals’ knowledge and confidence regarding
neonatal abstinence syndrome and the utilization of nonpharmacological interventions.
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CHAPTER I

Introduction

Over the past few decades the United States has been in the midst of an opioid
epidemic. This epidemic has not discriminated and has significantly affected pregnant
women, which has consequently caused an increase in infants being exposed to drugs inutero. This epidemic has resulted in infants being born and going through withdrawal
shortly after birth. This withdrawal is known as neonatal abstinence syndrome. “Neonatal
Abstinence Syndrome (NAS) is the result of sudden discontinuation of fetal exposure to
substances [legal or illegal] that were used or abused by the mother during her
pregnancy” (Kocherlakota, 2014, p. e547). This post-withdrawal syndrome produces both
behavioral and physiological signs and symptoms in the neonate, resulting in longer
hospital stays and increased cost of care.
Infants born suffering from NAS are typically admitted to a hospital’s Neonatal
Intensive Care Unit for an extended period of time to reduce withdraw symptoms and
stabilize the infant before discharge home. Treatment of NAS can include both
pharmacological interventions, most commonly morphine (Kocherlakota, 2014, p. e554),
and nonpharmacological interventions. However, “because of the complex nature of
withdrawal […] there are currently no uniformly accepted pharmacological interventions
or standardized regimens for the management of NAS” (Kocherlakota, 2014, p. e554).
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Nonpharmacological interventions are less controversial, less expensive, and have the
potential to reduce the average length of stay (Grossman, Berkwitt, Osborn, Xu,
Esserman, Shapiro, & Bizzarro, 2017, p.e4).
Significance of Clinical Problem
As the United States faces an increase in the use of, and dependence on,
controlled substances, especially opioids, the risk of infants being born with neonatal
abstinence syndrome also increases. According to Chiang, Okoroh, Kasehagen, GarciaSaavedra, and Ko (2019), the increase in NAS is attributed to the increase in maternal
opioid use, including misuse of prescribed opioids, use of illicit opioids such as heroin,
and the use of medication to help assist in the treatment of opioid use disorders such as
methadone. In 2000, opioid use in pregnant women was 1.1 per 1000 hospital deliveries
and has since increased to 6.5 per 1000 in 2014 (Chiang et al., 2019, p. 1193). “In the
past 10 years, rates of newborns diagnosed with NAS have risen fivefold in the United
States, from 1.5 per 1000 hospital births in 2004 to 8.0 in 2014” (Chiang, et al., 2019, p
1193) As the maternal use of opioids and illicit drugs continues to rise, the incidence of
NAS will also continue to rise, leading to more infant hospitalizations in the Neonatal
Intensive Care Unit, longer hospital stays for infants, and an increase in the cost of
healthcare for these infants.
According to Kocherlakota (2014), infants that are born with exposure to opioids
while in-utero and are consequently diagnosed with neonatal abstinence syndrome can
exhibit an adverse and wide variety of symptoms affecting the autonomic nervous
system, central nervous system, respiratory system, and the gastrointestinal system. NAS
can present with many different signs and symptoms ranging from mild to severe. The
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withdrawal symptoms that may manifest include, but are not limited to, “fever, sweating,
tachypnea, tremors, poor eating, weight loss, seizures, crying […]” (Allen, Prunty,
Babcock, Attarabeen, & Patel, 2018, p. 1750), excessive sneezing, excessive yawning,
excessive sucking, vomiting, diarrhea, and excoriations throughout the body
(Kocherlakota, 2014, p. e551- e552). Each symptom can manifest in varying degrees and
extremes, or may not manifest at all. Depending on the severity of these symptoms, many
infants require a prolonged and costly hospitalization in NICUs.
The average length of stay for infants suffering from NAS was “16 days and those
requiring pharmacologic treatment had a mean length of stay of 23 days” (Patrick, Davis,
Lehman, Cooper, 2015, p. 5) resulting in high healthcare costs. According to Corr and
Hollenbeak (2017), the significant increase in NAS admissions has resulted in a large
increase in annual healthcare costs. The annual healthcare related costs in 2003 for
infants with NAS were $61 million with a total of 67,869 hospital days. In 2012, the
annual costs had increased to $316 million with a total of 291,168 hospital days (Corr &
Hollenbeak, 2017, p. 1593). In comparison to an infant not affected by NAS, hospital
stays were three and a half times longer and cost three times more in infants suffering
from NAS.
Significance to Nursing
Nurses working in the Neonatal Intensive Care Units (NICU) provide direct care
to infants diagnosed with NAS. Patient assessments, administering medication treatment
regimens, educating family, and providing support to both infants and the family are all
tasks that nurses are at the forefront of providing. While caring for these infants does take
a collaborative effort between neonatologists, neonatal nurse practitioners, occupational
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therapists, physical therapists, speech therapists, social workers, and caregivers, nursing
plays a pivotal role. Nurses provide not only bedside care including comforting, feeding,
diaper changes, swaddling, and assessments but also care that extends past the bedside,
including parent support and education. Unfortunately, care extending beyond the
bedside also often includes legal matters that exist within the infant’s case.
Neonatal abstinence syndrome symptoms and their severity depend on multiple
factors, including: type of drug or drugs used, amount and frequency of drug/drugs used,
gestation of infant at birth, and the trimester in which the drugs were used (Kocherlakota,
2014, p. e551). However, “because NAS is a syndrome, there is a wide range of signs
that a neonate could display, and clinical assessment of these signs is not standardized
across practices” (Chiang, et al, 2019, p. 1193).
The overall goal of caring for these infants is effective management of the
withdrawal symptoms. Management can include both pharmacological and
nonpharmacological treatment methods. According to Allen et al. (2018),
“nonpharmacological therapy may reduce the length of hospitalization, minimizing
medication therapy requirements and reduce risk associated with medication therapy in
infants” (p. 1750).
Traditionally, neonates suffering from withdrawal are scored based on the
presence and severity of withdrawal symptoms. These symptoms are scored based on a
specific scoring tool, such as Finnegan Neonatal Abstinence Scoring Tool (FNAST),
Lipsitz Neonatal Drug Withdrawal Scoring System, and Neonatal Withdrawal Inventory
scoring system (NWI). The Finnegan scoring tool uses a 21-point item measuring
symptoms, can be utilized for both opioid and non-opioid withdrawal assessments and
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remains the most common tool utilized (Kocherlakota, 2014, p. e553). When utilizing the
Finnegan Scoring Tool, symptoms should be scored every three to four hours while the
infant is awake. Scoring should also take place after the infant has eaten, before an
assessment, during an assessment, and directly following an assessment (Kocherlakota,
2014, p. e553). Treatment protocols may differ from institution to institution, but the
higher the score leads to a higher incidence in pharmacological management rather than
nonpharmacological interventions. However, the first line of treatment should always be
nonpharmacological interventions. Examples of nonpharmacological interventions
include comfort measures, tight swaddling with lightweight blankets, providing quiet
environments, low lighting environments, massage, encouraging frequent uninterrupted
rest periods, rocking, use of a swing, pacifier use, frequent feedings, caregiver rooming
in, and if appropriate breastfeeding (Allen et al., 2018, p.1750; Kocherlakota, 2014, p.
e553). As a healthcare professional caring for these infants, the role is to provide these
nonpharmacological interventions to help the infant improve their symptoms in a more
comfortable environment.
Recently, studies began identifying the importance of nonpharmacological
interventions and their effects on infant outcomes and length of stay. “The first and
foremost goal of NAS care should be to establish an organized protocol with a
standardized scoring tool for NAS, as symptoms can be subjective. Nonpharmacological
therapy should be included in the protocol” (Allen, et al., 2018, p. 1750).
Nonpharmacological interventions are less controversial, less expensive, and can lead to
earlier discharges from the hospital. According to Kocherlakota (2014),
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“Nonpharmacological therapy is the first line in all cases [and] can be attempted in all
infants before pharmacological therapy” (p. e553).
Specific Purpose
The purpose of this Doctor of Nursing Practice (DNP) Scholarly Project was to
educate healthcare professionals caring for newborns diagnosed with Neonatal
Abstinence Syndrome on nonpharmacological interventions. Pharmacological
interventions can pose risks to the infant, while nonpharmacological interventions do not
possess the same potential adverse effects. The introduction of nonpharmacological
intervention education can aid in the standardization of treatment interventions for NAS
infants. This education for healthcare professionals can also be utilized to help educate
parents/family caregivers about the signs and symptoms of NAS and the appropriate
interventions to help provide comfort to the infant before initiating pharmacological
management.
Theoretical Framework
The theoretical framework chosen for this project is Orlando's Nursing Process
Discipline Theory (Figure 1). This theory focuses on a patient’s needs. The healthcare
professional’s role in this theory is to help discover and meet the immediate needs of the
patient, which would result in a positive outcome (Petiprin, 2016, para. 3). Healthcare
professionals must use their own intuition and critical thinking skills in order to discover
and meet the needs of the patients. This theory "focuses on the interaction between the
[healthcare professional] and patient, perception validation, and the use of the nursing
process to produce positive outcomes or patient improvement" (Petiprin, 2016, para. 9).
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The major assumptions from Orlando’s Nursing Process Discipline Theory
(Petiprin, 2016, para. 8) that apply to this project include:
•

When patients are unable to cope with their needs on their own, they
become distressed by feelings of helplessness.

•

In its professional character, nursing adds to the distress of the patient.

•

Patients are unique and individual in how they respond.

•

Nursing offers mothering and nursing analogous to an adult who
mothers and nurtures a child.

•

The practice of nursing deals with people, environment, and health.

•

Patients need help communicating their needs; they are uncomfortable
and ambivalent about their dependency needs.

•

The [healthcare professional-patient] situation is dynamic; actions and
reactions are influenced by both the nurse and the patient.

•

The patient is unable to state the nature and meaning of his or her
distress without the help of the [healthcare professional], or without
him or her first having established a helpful relationship with the
patient.

•

Any observation shared and observed with the patient is immediately
helpful in ascertaining and meeting his or her need, or finding out that
he or she is not in need at that time.

•

[Healthcare professionals] are concerned with the needs the patient is
unable to meet on his or her own.
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Figure 1
Theoretical Framework Model

Note: Adapted from Orlando’s Nursing Process Discipline Theory
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Practice Questions
The following are the practice questions that the DNP Scholarly Project will
address.
1. Prior to an educational offering, how frequently are healthcare
professionals caring for newborns in the hospital setting completing a
Finnegan Score on newborns born to women who tested positive for
substances known to cause NAS?
2. Prior to an educational offering on the nonpharmacological management
of NAS, which interventions are healthcare professionals caring for
newborns in the hospital setting implementing?
3. Will implementation of nonpharmacological intervention education
improve the knowledge of healthcare professionals caring for infants
diagnosed with NAS in the hospital setting?
4. Will implementation of nonpharmacological intervention education
improve the confidence of healthcare professionals caring for infants
diagnosed with NAS in the hospital setting?
Definition of Key Terms
Key terms used throughout the DNP project are listed and defined below.
•

Caregivers - The persons who will be caring for the infant diagnosed with
NAS outside of the hospital setting.

•

Finnegan Neonatal Abstinence Syndrome Scoring Tool (FNAST) - A
scoring tool used to quantify the symptoms of Neonatal Abstinence
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Syndrome. This tool helps to direct care towards nonpharmacological or
pharmacological interventions.
•

Healthcare Professionals - The persons who care for an infant diagnosed
with NAS while admitted to an inpatient care facility, including certified
nurse aids, registered nurses, lactation consultants, social workers,
physician’s assistants, nurse practitioners, and physicians.

•

Neonatal Abstinence Syndrome - The result of sudden discontinuation of
fetal exposure to substances, legal or illegal, that were used or abused by
the mother during her pregnancy (Kocherlakota, 2014, p. e547).

•

Neonatal Intensive Care Unit (NICU) - A unit within a hospital that
specializes in the care of critically ill infants.

•

Nonpharmacological Intervention Education - An educational presentation
utilized by healthcare professionals and caregivers to help identify
appropriate nonpharmacological interventions for infants with NAS.
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Logic Model
Figure 2
Logic Model
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Summary
Neonatal abstinence syndrome is a complex condition that affects infants who
were exposed to legal and illegal substances in utero. The exposure to these substances
results in withdrawal from the substance or substances. Potential symptoms that may be
experienced include excessive sweating, fevers, high-pitched cry, poor feedings, tremors,
excessive sucking, excessive sneezing, excessive yawning, and excoriations throughout
the body.
Neonatal abstinence syndrome is an unfortunate consequence of the increasing
opioid epidemic within the United States. The goal of this project is to offer alternative
and effective treatment strategies for neonatal abstinence syndrome—through the
introduction of education addressing nonpharmacological interventions that can help
comfort the infant and manage symptoms that manifest during the withdrawal period.
This education will be aimed to help aid healthcare professionals and caregivers in their
care practices.
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CHAPTER II

Integrated Review of the Literature

As stated in the introductory chapter, the incidence of neonatal abstinence
syndrome has increased drastically in the past decade, which is attributed to the increased
incidence of maternal substance abuse (Chiang et al., 2019, p. 1193). Recent research has
guided changes in clinical practice guidelines, moving from treatment of NAS with
pharmacological measures to first line therapy being nonpharmacological interventions.
Research has shown improved patient outcomes, reduced length of stay, and improved
bonding with caregivers with the implementation of nonpharmacological interventions
(MacVicar & Kelly, 2019). The increased incidence of NAS should provide the
motivation for healthcare providers to improve treatment interventions.
A review of the literature related to NAS was conducted using CINHAL PLUS
with full text and UpToDate electronic databases. Search terms that were utilized
included “neonatal abstinence syndrome,” “neonatal abstinence syndrome and
management,” “neonatal abstinence syndrome and nonpharmacological interventions,”
“neonatal abstinence syndrome and length of stay,” “neonatal abstinence syndrome and
cost of care,” “neonatal abstinence syndrome treatment,” and “neonatal abstinence
syndrome and incidence.” Utilizing these terms and phrases, the articles were reviewed
for relevance, and selected accordingly. Publication dates utilized for this literature
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review ranged from 2010 to 2020. Ancestral research was also performed by utilizing the
reference lists of the selected articles. This ancestral research allowed for the
identification of new sources of information. The review of literature gave insight on
neonatal abstinence syndrome, nonpharmacological interventions for neonatal abstinence
syndrome, the link between nonpharmacological interventions and infant outcomes, the
link between nonpharmacological interventions and infant length of stay, and financial
burdens due to neonatal abstinence syndrome.
The purpose of this literature review was to gain knowledge on neonatal
abstinence syndrome, symptoms scoring tools, management of NAS including
pharmacological and nonpharmacological interventions, and healthcare expenditures due
to NAS. The knowledge obtained in the literature review will be presented to healthcare
professionals caring for newborns in a hospital setting through an educational offering as
part of the scholarly project. By increasing the nonpharmacological intervention
knowledge of healthcare professionals caring for newborns in a hospital setting,
newborns suffering from neonatal abstinence syndrome will receive higher and improved
quality of care while hospitalized.
Neonatal Abstinence Syndrome
“Neonatal Abstinence Syndrome (NAS) is the result of sudden discontinuation of
fetal exposure to substances [legal or illegal] that were used or abused by the mother
during her pregnancy” (Kocherlakota, 2014, p. e547). This post-withdrawal syndrome
produces both behavioral and physiological signs and symptoms in the neonate, resulting
in longer hospital stays and increased cost of care. The subsequent sections of this
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chapter will review NAS incidence, the impact of NAS signs and symptoms, scoring
tools, management, cost of care, and length of stay in relation to an NAS diagnosis.
Incidence. As previously stated, substance abuse disorders among pregnant
women have increased dramatically in the past decade, consequently resulting in
increased incidence of neonatal abstinence syndrome. Between the years 2004 and 2010,
the incidence of newborns diagnosed with NAS increased fivefold, which has inevitably
increased the number of newborns requiring longer hospitalization and specialized care
(Chiang et al., 2019, p. 1193). The diagnosis of NAS is a result of the abrupt
discontinuation of substances used by a mother during pregnancy (Kocherlakota, 2014, p.
e548) and has spread across socioeconomic statuses (Washington & Wilson, 2019, p. 48).
Impact and Symptoms. Many different substances, legal or illegal, can result in
NAS. These substances include prescription opioids, heroin, cocaine, methamphetamines,
methadone, buprenorphine, antidepressants, anxiolytics, synthetic narcotics,
hallucinogens, and kratom. (Artigas, 2014, p. 510; Kocherlakota, 2014, p. e549; &
Jansson, 2020, p. 2). Infants exposed to these substances while in-utero have the potential
of NAS after birth, which can lead to a variety of problems. These problems include
gastrointestinal, metabolic, and central nervous system effects (Allen et al., 2018, p.
1750).
According to the literature, symptoms of NAS can vary vastly and are dependent
upon multiple factors such as last maternal substance use, substance type, amount, halflife, and singular or polysubstance exposure (Cook & Fantasia, 2019, p. 359;
Kocherlakota, 2014, p. e551). NAS can present with many different signs and symptoms
ranging from mild to severe. Presentation of signs and symptoms can include tremors,
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irritability, excessive, high-pitched and inconsolable crying, diarrhea, jitteriness,
agitation, short or irregular sleep patterns, hypertonia, myoclonic jerks, seizures,
increased heart rate and respiratory rate, temperature instability, sweating, frequent
sneezing, frequent yawning mottling, nasal flaring, nasal stuffiness, poor feedings,
regurgitation, excoriations, hyperphagia, excessive sucking, and poor weight gain
(Artigas, 2014, p. 511; Cook & Fantasia, 2019, p. 358; Kocherlakota, 2014, p. e551e552).
Symptom Scoring Tools. Assessments and the use of scoring tools allows for
providers to initiate appropriate interventions when treating NAS. The most frequently
utilized scoring tool is the Finnegan Neonatal Abstinence Scoring Tool (FNAST);
however, other scoring tools include Lipsitz Neonatal Drug Withdrawal Scoring System,
and the Neonatal Withdrawal Inventory (NWI) scoring system (Artigas, 2014). NAS
scoring tools help healthcare professionals and caregivers to quantify the severity of NAS
symptoms and therefore guide treatment. Additionally, according to Cook and Fantasia
(2019), hospitals have started to adopt a new assessment tool that focuses less on
numerical scoring and more on the behavior of the neonate. This scoring method is
referred to as the Eat, Sleep, Console (ESC) method and focuses primarily on
nonpharmacological interventions. This project utilized the Finnegan Scoring Tool.
The Finnegan Scoring Tool was developed by Loretta Finnegan in 1975 as both a
clinical and investigative tool (Zimmerman, Nötzli, Rentsch, & Bucher, 2010). The tool
assesses “central nervous system hyperirritability, gastrointestinal dysfunction,
respiratory distress and vague autonomic signs in a semi quantitative way” (ZimmermanBaer et al., 2010, p. 524). The tool includes a list of 21 different symptoms that an infant
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may display while experiencing NAS. The 21 symptoms are given a score based on
manifestation and severity to quantify severity. Once an infant “scores greater than or
equal to 12 at two consecutive assessments, or greater than or equal to a score of 8 at
three consecutive assessments, pharmacological intervention is initiated” (Cook &
Fantasia, 2019). Appropriate education and training for healthcare providers and
caregivers is essential for providing consistency while performing NAS assessments and
assigning scores.
Management
Management of NAS is an important factor in overall infant outcomes and can
include both pharmacological and nonpharmacological interventions. Treatment
modalities should begin with nonpharmacological interventions followed by
pharmacological interventions when withdrawal symptoms are unable to be reduced by
nonpharmacological interventions.
Pharmacologic. According to Kocherlakota (2014), there is no uniformly
accepted standardized protocol or regimen for the management of NAS with
pharmacological interventions. However, literature is consistent in stating that morphine
is the most commonly utilized medication (Cook & Fantasia, 2019, p. 361; Jansson,
2020, p. 14; Kocherlakota, 2014, p. e554). Other medications that can be utilized include
methadone, buprenorphine, clonidine, and phenobarbital (Cook & Fantasia, 2019;
Kocherlakota, 2014). Though medication modalities can help to reduce withdrawal
symptom severity, the use of pharmacological therapy ultimately increases average
length of stay and associated healthcare costs (Grossman et al., 2017). With proper
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education and training, the utilization of these medications can be avoided with the use of
intensive nonpharmacological interventions.
Nonpharmacological. Nonpharmacological interventions should always be first
line therapy for management of NAS and require “thorough evaluation of the newborn’s
behaviors and responses to interactions and the environment to determine the need for
specific soothing techniques” (Artigas, 2014, p. 511). Nonpharmacological interventions
have been shown to reduce the length of hospitalizations, minimize medication therapy,
improve infant outcomes, and ultimately reduce healthcare associated costs (Allen et al.,
2018; Kocherlakota, 2014). Examples of nonpharmacological supportive care include
gentle handling, on demand feedings, swaddling, dim light, low noise, frequent feedings,
utilizing high calorie formulas, holding, cuddling, manual rocking, aromatherapy,
massage therapy, skin-to-skin contact, pacifier use to promote “self-soothing”, caregiver
rooming-in, breastfeeding, and increasing parent/caregiver infant care (Allen et al., 2018;
Artigas, 2014; Cook & Fantasia, 2019; Jansson, 2020; Kocherlakota, 2014; MacVicar &
Kelly, 2019). These interventions should be utilized by parents, caregivers, volunteers,
and healthcare professionals to improve quality of care for infants diagnosed with NAS.
If withdrawal symptoms are not well controlled with current interventions, the caregiving
team must re-evaluate and adjust interventions accordingly.
Cost and Length of Stay. A quality improvement initiative developed and
implemented by Grossman et al. (2017) and a multidisciplinary team showed a reduced
average length of stay for infants diagnosed with NAS by implementing intensive
nonpharmacological interventions. The multidisciplinary team initiated four main
nonpharmacological interventions. These interventions included placing infants in low
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stimulation environments with dim lighting and reduced noise, engaging parents in the
care of the newborns by encouraging rooming in and feeding on demand, training staff to
view nonpharmacological interventions as equivalent to pharmacological interventions,
and encouraged breastfeeding of all infants unless contraindicated due to illicit drug use
(Grossman et. al., 2017). Conclusions of the quality improvement initiative showed that
by modifying how infants with NAS are managed the average length of stay is reduced
from an average of 23 days to an average of six days and overall quality of care was
improved substantially.
Similarly, in a mixed study review of 14 studies on nonpharmacological
interventions for infants diagnosed with NAS, MacVicar and Kelly (2019) found that the
implementation of nonpharmacological interventions led to a reduction in length of
hospitalization and a decreased need for pharmacological interventions. Each study
showed a decrease in length of stay and a decreased need for pharmacologic therapy
when nonpharmacological interventions were initiated early.
Healthcare Expenditures. As the incidence of maternal substance abuse and
NAS increase, the more hospitalizations and healthcare costs also increase. According to
a retrospective, observational study completed by Corr and Hollenbeak (2017), between
2003 and 2012, the number of infants born and hospitalized with a diagnosis of NAS
increased fourfold. This fourfold increase resulted in a total of 67,869 hospital days and
$61 million in healthcare costs in 2003 compared to 291,168 hospital days and $316
million in healthcare costs in 2012 (Corr & Hollenbeak, 2017, p. 1590). By 2014, the
healthcare costs of NAS had increased to $462 million (Winkleman, Villapiano,
Kozhimannil, Davis, & Patrick, 2018, p. 1).The study conducted by Corr and Hellenbeak
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(2017) concluded that this increase included the length of stay being 3.5 times longer for
NAS diagnosed infants versus infants without NAS. The average cost of admission and
hospital stay for a newborn not affected by NAS was an average of $18,518.72 compared
to the average cost of admission and hospital stay for an infant not affected by NAS of
$5,429.28 (Corr & Hollenbeak, 2017, p. 1593-1595).
According to a quality improvement initiative to improve the quality of care NAS
infants received by utilizing nonpharmacological interventions by Grossman et al. (2017),
the average length of stay for all infants with NAS was 17 days and the average length of
stay for infants with NAS requiring pharmacological management was 23 days.
Grossman et al. (2017) concluded that by initiating nonpharmacological interventions in
the treatment of NAS, the average length of stay and average cost of stay was
significantly decreased.
Summary
The review of literature revealed that though there are significant benefits of
utilizing nonpharmacological interventions in the care of NAS, there is still a gap in
practice protocols and guidelines. Pharmacological therapy has traditionally been known
to help reduce the symptoms of NAS, but at what cost? The literature remained consistent
in concluding that nonpharmacological interventions promote parent/caregiver bonding,
improve infant outcomes, reduce length of hospitalizations, and ultimately reduce
healthcare expenditures. The positive outcomes of nonpharmacological interventions
included in this literature review provided significant evidence that NAS can be managed
successfully while also reducing length of hospitalizations and reduced healthcare costs.
Healthcare professionals providing care to infants diagnosed with NAS have a duty to
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advocate and participate in the development of improved evidence-based guidelines and
protocols to improve infant outcomes by utilizing nonpharmacological interventions in
the treatment of neonatal abstinence syndrome.
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CHAPTER III

Methodology

The increasing incidence of neonatal abstinence syndrome should be of great
concern to healthcare providers, especially for healthcare professionals caring for
newborns that are diagnosed with NAS. Healthcare professionals caring for newborns are
in a position to help improve infant outcomes and reduce not only length of stay but also
reduce healthcare costs when caring for infants diagnosed with NAS by utilizing
nonpharmacological interventions. The goal of this project was to increase healthcare
professionals’ confidence, knowledge of, and intent of utilizing nonpharmacological
interventions in the treatment of NAS. Through an educational presentation, healthcare
professionals caring for newborns in a hospital setting will be better equipped and
prepared to care for infants diagnosed with NAS, which will ultimately improve patient
care and outcomes. This chapter details the design of the scholarly project.
Project Design
This study was designed to determine if the knowledge and confidence of
healthcare professionals caring for newborns in the hospital setting would increase after
an educational presentation was provided. This educational presentation introduced and
explained neonatal abstinence syndrome and nonpharmacological interventions that can
be implemented when treating an infant with NAS. The education was provided in a
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voice recorded PowerPoint presentation. The educational presentation included a
pre/post-test survey, as well as a follow-up posttest survey occurring six weeks later. The
focus of the study was to increase the utilization of nonpharmacological interventions
when caring for infants diagnosed with NAS by increasing healthcare professionals’
knowledge and confidence. Nonpharmacological intervention knowledge and confidence
levels were screened before the educational presentation, immediately after the
educational presentation, and again six weeks post educational presentation.
The educational presentation was provided to healthcare professionals who care
for newborns in a hospital setting. Prior to the educational presentation, a pre-test survey
was provided to participants to determine their current knowledge, confidence, and
utilization of nonpharmacological interventions while caring for infants diagnosed with
NAS. The posttest and six-week follow-up posttest assessed if the educational
presentation increased the healthcare professionals’ knowledge and understanding of
NAS, confidence in providing nonpharmacological interventions, and the intent to utilize
nonpharmacological interventions when caring for infants diagnosed with NAS.
Setting and Participants
The target population included healthcare professionals who care for newborns in
a hospital setting. The participants were able to access the educational learning program
asynchronously at their convenience to gain knowledge of nonpharmacological
interventions in the treatment of NAS. A convenience sampling of certified nurse aids
(CNAs), registered nurses (RNs), lactation consultants (LCs), social workers, physician’s
assistants (PAs), nurse practitioners (NPs), and physicians (MD or DO) was utilized. The
convenience sample was obtained by contacting colleagues known to work as healthcare
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professionals caring for newborns in a hospital setting and asking them to participate.
These colleagues were also asked to share the educational presentation and survey link
with other healthcare professionals within their personal network, resulting in a snowball
technique. E-mail, telephone contact, personal contact, and social media were utilized to
recruit participants. All participants who participated in the educational presentation
received a pretest and posttest. Participants had the option to complete a six-week followup posttest survey if they elected to provide their email address. Inclusion criteria
included the participant being a healthcare professional caring for newborns in the
hospital setting with a valid healthcare professional license, 18 years of age or older, and
English speaking. Exclusion criteria included the participant being younger than 18 years
of age, non-English speaking, and healthcare professionals who do not care for newborns
in the hospital setting.
Protection of Human Subjects
An Institutional Review Board (IRB) application was submitted to the Pittsburg
State University Committee for the Protection of Human Research Subjects (CPHRS) for
review and approval. The target population included adult subjects with a healthcare
professional license. All surveys were answered confidentially and confidentiality was
maintained throughout the research process. There were minimal risks associated with the
pretest and posttest. The survey responses remained anonymous.
The project data was obtained through the pretest, posttest, and six-week followup posttest. The educational presentation was strictly voluntary and no monetary
compensation was provided. The data from the pretest, posttest, and six-week posttest
was analyzed using descriptive and t-test statistics to determine if knowledge and
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confidence in providing nonpharmacological interventions for the management of NAS
increased after healthcare professionals caring for newborns in a hospital setting
completed the educational presentation. The pretest, posttest, and six-week follow-up
posttest maintained confidentiality and were provided through Qualtrics.
Instruments
This study utilized three online surveys to obtain data including a pretest, posttest,
and six-week follow-up posttest if participants chose to provide their email. Each survey
was administered through the third-party online survey software Qualtrics. The surveys
included a pretest prior to the educational presentation, posttest immediately following
the educational presentation, and a six-week posttest. The surveys assessed
demographics, knowledge, confidence, and personal thoughts on NAS management and
interventions from the participants’ experience. The surveys included both forced choice
and open-ended questions, as well as a comment section at the end. The data from the
pretest, posttest, and six-week posttest was analyzed using descriptive and t-test statistics
to determine if knowledge of nonpharmacological interventions increased, confidence in
providing nonpharmacological interventions increased, and if nonpharmacological
interventions were more frequently utilized. The pretest, posttest, and six-week posttest
were reviewed by Pittsburg State University School of Nursing Faculty members to
ensure content validity.
Procedure
The timeline of the project was as follows: The proposal was sent to the proposal
committee on October 27, 2020. A meeting via ZOOM with the proposal committee took
place on November 10, 2020. At this proposal meeting, project content, ideas, and
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organizational structure were discussed. On December 1, 2020, Pittsburg State University
IRB was approved. The educational presentation, pretest and posttests were then
provided and data was collected between December 2020 and January 2021. The
proposal defense then took place on April 5, 2021 and consisted of Pittsburg State
University School of Nursing Faculty members as well as a member of the Pittsburg State
University Department of Psychology and Counseling.
The educational offering was a web-based distant learning opportunity provided
through the third-party software Qualtrics. The educational presentation included a
pretest, recorded educational presentation, handouts, and posttest. Participants were asked
to provide an email address if they were willing to participate in a six-week follow-up
posttest. Provision of the email address was optional.
Treatment of Data/Outcomes/Evaluation Plan
Education regarding neonatal abstinence syndrome and nonpharmacological
interventions for NAS infants was provided to healthcare professionals caring for
newborns in a hospital setting December 2020 through January 2021. Pretest and posttest
surveys were utilized to assess individual knowledge, confidence, and current practice.
The pretest and posttests included questions over sociodemographic data, knowledge,
confidence level, utilization of nonpharmacological interventions, and barriers to care.
The pretest and posttests were distributed to participants immediately prior to the
education, immediately following the education, and six weeks after the education.
Evaluation Measures Linked to Objectives
The purpose of this study was to evaluate prevailing attitudes, practices,
knowledge, and confidence of healthcare professionals regarding current care of infants
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diagnosed with NAS. Pretest and posttest surveys were administered via the third-party
web-based software Qualtrics. The results of this study were analyzed to determine if
knowledge of nonpharmacological interventions increased among healthcare
professionals and if there was an increase in the intent to utilize nonpharmacological
interventions after the educational presentation was presented.
Methods of Analysis. The data from the surveys was analyzed using descriptive
and t-test statistics to determine if knowledge and confidence in the utilization of
nonpharmacological interventions for the management of NAS increased after healthcare
professionals caring for newborns in a hospital setting completed the education.
Descriptive statistics included gender, age, NAS knowledge, and confidence. A paired ttest for summative average was utilized via SPSS to compare average scores of survey
responses pre and post NAS education. The pretest and posttests maintained
confidentiality and were provided through Qualtrics.
Plan for Sustainability
Sustainability of this project was key in increasing healthcare providers’
knowledge and confidence in caring for infants diagnosed with NAS. This education will
help healthcare providers provide higher quality of care and stay up to date on current
clinical practice guidelines, potentially reducing pharmacological interventions when
caring for an infant with NAS. The potential for reduced pharmacological interventions
can lead to decreased length of hospitalization stays as well as decreased healthcare costs.
Sustainability will be improved with timing. Strategies for timing include
education delivery during provider orientation as well as re-education on an annual basis.
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Early education in conjunction with annual education will keep healthcare provider
knowledge and confidence high when providing care to an infant diagnosed with NAS.
Summary
The increasing incidence of neonatal abstinence syndrome should be of great
concern to healthcare providers, especially for healthcare professionals caring for
newborns that are diagnosed with NAS. Healthcare professionals are important advocates
to help improve infant outcomes and reduce not only length of stay but also reduce
healthcare costs when caring for infants diagnosed with NAS by utilizing
nonpharmacological interventions. Studies have shown that the utilization of
nonpharmacological interventions in the management of NAS improves overall infant
outcomes. The goal of this project was to increase healthcare professionals’ knowledge,
confidence, and intent of utilizing nonpharmacological interventions in the treatment of
NAS by providing education. Through education, healthcare professionals caring for
newborns in a hospital setting will be better equipped and prepared to provide care to
infants diagnosed with NAS, which will ultimately improve the quality of patient care
and outcomes.
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CHAPTER IV

Evaluation of Results

The purpose of this Doctor of Nursing Practice (DNP) scholarly project was to
educate healthcare professionals caring for newborns diagnosed with neonatal abstinence
syndrome (NAS) on nonpharmacological interventions. A pretest was given to healthcare
professionals to identify current knowledge, confidence, and utilization of
nonpharmacological interventions when caring for newborns diagnosed with NAS.
Following the pretest, the researcher provided an educational offering in the form of a
voice-recorded PowerPoint presentation through the third-party software Qualtrics. The
educational offering introduced and explained neonatal abstinence syndrome, neonatal
abstinence syndrome signs and symptoms, medications and drugs that can lead to
neonatal abstinence syndrome, and nonpharmacological interventions that can be utilized
when treating an infant with neonatal abstinence syndrome. After viewing the educational
offering, healthcare professionals completed a posttest to determine if knowledge and
confidence of neonatal abstinence syndrome and the utilization of nonpharmacological
interventions in the treatment of neonatal abstinence syndrome increased after receiving
education on the topic. Healthcare providers were then given the option to participate in a
six-week follow-up posttest to determine if knowledge and confidence levels remained
increased after the educational offering.
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Description of Population
A convenience sampling of healthcare professionals, which included certified
nurse aids (CNAs), registered nurses (RNs), lactation consultants (LCs), social workers,
physician’s assistants (PAs), nurse practitioners (NPs), and physicians (MD or DO) were
included in this study. Participants were recruited by contacting colleagues known to
work as healthcare professionals caring for newborns in a hospital setting and asking
them to participate. These colleagues were then asked to share the educational video and
pre/posttest link with other healthcare professionals within their personal network,
resulting in a snowball technique. Email, telephone contact, personal contact, and social
media platforms were utilized to recruit participants. Inclusion criteria required
participants to be healthcare professionals caring for newborns in a hospital setting, at
least 18 years of age, and who utilized English as their primary language. Demographic
data was divided into age, gender, profession, and length of time caring for newborns in a
professional setting.
After pretest and posttest completion, the data was aggregated to form a total
sample population of forty-seven participants. The pretest and posttest took place in the
months of December 2020 and January 2021 via Qualtrics. Prior to viewing the
educational presentation, participants completed a pretest assessing demographics,
knowledge, and confidence levels. Immediately following the educational presentation,
participants were given a posttest, which had identical questions as the pretest excluding
demographic data. The posttest also gave participants the option to provide their email if
they were willing to participate in a six-week posttest follow-up. Of the forty-seven
participants only thirty participants completed the full pretest, educational presentation,
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and posttest. Of the thirty participants that completed the full education, eight participants
chose to participate in the six-week posttest follow-up.
Six weeks after education, participants were sent an email with the posttest
education follow-up, which was identical to the posttest that immediately followed the
educational offering. In total, eight six-week follow-up posttests were emailed and five
responses were received. For accurate data comparison, the remainder of the data
analyzed only compares results of participants who completed both pretest and posttest.
The six-week follow-up posttest results were disregarded due to the small sample size.
The thirty total participants of this study all (100%) identified with the female
gender and thirty (100%) selected nurse as their primary role. Of the thirty participants,
one (3.33%) was between the ages of eighteen and twenty-one, fourteen (46.67%) were
between the ages of twenty-one and thirty, six (20%) were between the ages of thirty-one
and forty, six (20%) were between the ages of forty-one and fifty, one (3.33%) was
between the ages of fifty-one and sixty, and two (6.67%) were sixty-one years old or
greater (Figure 3).
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Figure 3
Participant Age

The participants’ years of practice caring for newborns in a hospital setting
varied. Among the participants, the majority had practiced greater than 10 years
(36.67%). Other categories based on years of experience included participants who have
been practicing for 6-10 years (26.67%), practicing for 1-5 years (33.33%), and
practicing for one year or less (5.71%) (Figure 4).
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Figure 4
Participant Years of Practice Caring for Newborns

Analysis of Project Questions
This study utilized a pretest, educational presentation, and posttest with the option
to participate in a six-week follow-up posttest to evaluate whether the educational
presentation increased healthcare professionals’ knowledge of and confidence in utilizing
nonpharmacological interventions when caring for an infant diagnosed with NAS. Data
from the pretest was compared to the data from the posttest to determine if knowledge
and confidence changed. There were four project questions addressed in this project.
Each project question will be reviewed individually to ensure it is answered.
Project Question One. Prior to an educational offering, how frequently are
healthcare professionals caring for newborns in the hospital setting completing a
Finnegan Score on newborns born to women who tested positive for substances known to
cause NAS?
First, participants were asked to identify how frequently they care for infants
diagnosed with or showing signs and symptoms of NAS. Participants could indicate that
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they care for infants diagnosed with NAS or showing signs/symptoms of NAS less than
once a month, one to two times a month, three to five times a month, more than five
times a month, or that they have never cared for an infant diagnosed with or displaying
signs/symptoms of NAS. Of the thirty pretest participants, 43.33% (n=13) responded that
they care for infants diagnosed with or showing signs/symptoms of NAS one to two times
per month. Additionally, 33.33% (n=10) selected less than once a month, 20% (n=6)
selected three to five times per month, 2.86% (n=1) selected they had never cared for an
infant diagnosed with or displaying signs/symptoms of NAS, and no participants selected
more than five times per month. (Table 1).
Table 1
Participant Frequency of Caring for NAS Diagnosed Infants
Frequency of Care

Participants
(n=30)

Percent
(%)

Less than 1 time per month

10

33.33

1-2 times per month

13

43.33

3-5 times per month

6

20.00

Greater than 5 times per month

0

0

Never

1

3.33

Total

30

100.00

Second, participants were asked how frequently the Finnegan Neonatal
Abstinence Syndrome Scoring System Tool (FNAST) was being utilized when caring for
an infant exposed to substance abuse in utero. Participants could indicate the utilization
of the FNAST was occurring every two hours, every three hours, every four hours, every
six hours, every eight hours, every twelve hours, as needed, or that their facility utilizes a
different scoring tool with instructions to specify which tool. Of the thirty pretest
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participants, 13.33% (n=4) indicated they score every two hours, 30% (n=9) indicated
that they score every three hours, 20% (n=6) indicated that they score every four hours,
16.67% (n=5) indicated they score as needed, and 20% (n=6) indicated their facility
utilizes a different scoring tool (Table 2). The participants that indicated their facility
utilizes a different scoring tool stated they utilize the Eat, Sleep, Console Method.
Table 2
Frequency of Utilization of Finnegan Neonatal Abstinence Scoring Tool
Frequency of Scoring
Every 2 Hours

Participants
(n=30)
4

Percent
(%)
13.33

Every 3 Hours

9

30.00

Every 4 Hours

6

20.00

Every 6 Hours

0

0

Every 8 Hours
Every 12 Hours

0
0

0
0

As Needed

5

16.67

Use a Different Scoring Tool

6

20.00

Total

30

100.00

Project Question Two. Prior to an educational offering on the
nonpharmacological management of NAS, which interventions are healthcare
professionals caring for newborns in the hospital setting implementing?
Study participants were asked to identify nonpharmacological interventions they
currently implement when caring for infants diagnosed with or displaying
signs/symptoms of NAS. Participants answered the question via an open-ended text entry
submission. Participant responses were reported prior to the educational presentation
offering. Participants responded with several nonpharmacological interventions which
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included rooming-in, consoling, quiet environments, dim lighting, low stimulation, skin
to skin, frequent feeds, long rest periods, low noise, tight swaddling, containment,
rocking, offering pacifiers, utilizing an infant swing, music therapy, utilizing sucrose,
utilizing sensitive formula, clustered care, tummy time, patting, repositioning, and family
involvement.
Project Question Three. Will implementation of nonpharmacological
intervention education improve the knowledge of healthcare professionals caring for
infants diagnosed with NAS in the hospital setting?
The correlation between neonatal abstinence syndrome education pretest and
posttest was answered using data collected on pretest questions nine through eleven and
posttest questions one through three. The participants were provided a five-point Likert
rating scale presenting a statement with a one being very poor and five being very good.
The questions were identical for both pretest and posttest. Participants were asked to rate
current knowledge of neonatal abstinence syndrome, Finnegan Neonatal Abstinence
Syndrome Scoring System Tool, and nonpharmacological interventions utilized for
neonatal abstinence treatment. The responses to each of the five knowledge areas from
the pretest are in Table 3 and those from the posttest are in Table 4. An overall
summative average of participant perception of knowledge pre and post education was
compared (Table 5).
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Table 3
Pretest Average of Responses to Individual Knowledge Items
Topic

Mean

Std.
Deviation

Neonatal Abstinence Syndrome Overall

3.73

0.77

Finnegan Neonatal Abstinence Scoring System Tool

3.67

0.82

Nonpharmacological Interventions for the Treatment
of NAS

3.77

0.85

Note. For observed means, 1=very poor; 2=poor; 3=fair; 4=good; 5=very good.
Table 4
Posttest Average of Response to Individual Knowledge Items
Topic

Mean

Std.
Deviation

Neonatal Abstinence Syndrome Overall

4.33

0.83

Finnegan Neonatal Abstinence Syndrome Scoring
Tool

4.13

0.85

Nonpharmacological Interventions for the Treatment
4.47
0.88
of NAS
Note. For observed means, 1=very poor; 2=poor; 3=fair; 4=good; 5=very good.
Using a five-point Likert scale from very poor to very good, participants’
responses to each individual item were analyzed. Responses were evaluated by the
following scores: Very Poor (0-1.49), Poor (1.5-2.49), Fair (2.5-3.49), Good (3.5-4.49),
and Very Good (4.5-5). All the mean individual responses for each item on the pretest
and posttest fell between 3.5 and 4.49 or having “good” perception of knowledge both
before and after the presentation. However, there was an increase in the respondents’
perception of knowledge after the educational presentation.
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Table 5
Summative Average of Knowledge Items

Pre-Summative Average of Knowledge

Mean

N

Std.
Deviation

3.72

30

0.81

Post-Summative Average of Knowledge
4.31
30
0.85
Note. For observed means, 1=very poor; 2=poor; 3=fair; 4=good; 5=very good.
The pre-summative mean (3.72) indicates that participants had a “good” (3.54.49) perception of knowledge of individual items prior to the educational presentation.
The post-summative mean (4.31) indicates that participants had an increase of points
(0.59) indicating a “good” (3.5- 4.49) perception of knowledge after the educational
presentation.
Table 6
Paired Sample Statistics for Knowledge Items
Mean
Difference

Std.
Deviation

t

df

Sig. (2tailed)

Neonatal Abstinence Syndrome
Overall

.600

.855

3.844

29

< .001

Finnegan Neonatal Abstinence
Syndrome Scoring Tool

.467

.776

3.294

29

.003

Nonpharmacological Interventions
for the Treatment of NAS

.700

1.149

3.339

29

.002

Paired Samples t-tests were calculated to see if there were statistical differences
between the pre and post measures of participant perceived knowledge after the
educational presentation. There was statistical difference between the pre and post
measure for participant knowledge level for each knowledge item, neonatal abstinence
syndrome overall ( t= 3.844, p < .001), Finnegan Neonatal Abstinence Syndrome Scoring
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Tool ( t= 3.294, p = .003), and nonpharmacological interventions for the treatment of
NAS ( t= 3.339, p = .002).
Project Question Four. Will implementation of nonpharmacological intervention
education improve the confidence of healthcare professionals caring for infants diagnosed
with NAS in the hospital setting?
The confidence level of healthcare professionals was assessed with the pretest
questions twelve through fifteen and posttest questions four through seven. Participants
were asked to rate their current confidence in caring for an infant diagnosed with NAS,
recognizing signs/symptoms of NAS, utilizing the Finnegan NAS scoring system tool,
and implementing nonpharmacological interventions. The participants were provided a
three-point Likert scale to rate their confidence in four areas of care. Responses were
evaluated by the following scores: Not Confident (0-1.00), Somewhat Confident (1.012.00), and Completely Confident (2.01-3). On both the pretest (Table 7) and posttest
(Table 8), all the mean individual responses fell between 2.01 and 3.00 or Completely
Confident. An overall summative average of participant perception of confidence pre and
post education was compared (Table 9).
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Table 7
Pretest Average of Responses to Individual Confidence Items
Topic

Mean

Std.
Deviation

Caring for an Infant Diagnosed with NAS

2.13

0.62

Recognizing signs/symptoms of NAS

2.47

0.56

Utilizing the Finnegan Scoring System Tool

2.27

0.68

Implementing Nonpharmacological
2.23
0.56
Interventions when Caring for NAS Diagnosed
Infant
Note. For observed means, 1=Not Confident; 2=Somewhat Confident; 3=Completely
Confident.
Table 8
Posttest Average of Responses to Individual Confidence Items
Topic

Mean

Std.
Deviation

Caring for an Infant Diagnosed with NAS

2.60

0.49

Recognizing signs/symptoms of NAS

2.73

0.44

Utilizing the Finnegan Scoring System Tool

2.50

0.50

Implementing Nonpharmacological
2.77
0.42
Interventions when Caring for NAS Diagnosed
Infant
Note. For observed means, 1=Not Confident; 2=Somewhat Confident; 3=Completely
Confident.
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Table 9
Summative Average of Confidence Items

Pre-Summative Average of Confidence

Mean

N

Std.
Deviation

2.28

30

0.61

Post-Summative Average of
2.65
30
0.46
Confidence
Note. For observed means, 1=Not Confident; 2=Somewhat Confident; 3=Completely
Confident.
The pre-summative mean (2.28) indicates participants were “completely
confident” (2.01- 3) prior to the educational presentation. The post-summative mean
(2.65) shows participants had an increase of points (0.37), indicating that participants
remained “completely confident” (2.01- 3) after the educational presentation.
Table 10
Paired Sample Statistics for Confidence Items
Mean
Difference

Std.
Deviation

t

df

Sig. (2tailed)

Caring for an Infant Diagnosed
with NAS

.467

.507

5.037

29

< .001

Recognizing Signs/Symptoms
of NAS

.267

.521

2.804

29

.009

Utilizing the Finnegan Scoring
System Tool

.233

.568

2.249

29

.032

Implementing
Nonpharmacological Interventions

.533

.571

5.113

29

< .001

Paired Samples t-tests were calculated to determine if there were statistical
differences between the pre and post measures of participant perceived confidence after
the educational presentation. There was statistical difference between the pre and post
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measure for participant confidence for each item, caring for an infant diagnosed with
NAS (t= 5.037, p < .001), recognizing signs/symptoms of NAS ( t= 2.804, p = .009),
utilizing the Finnegan Scoring System Tool (t= 2.249, p = .032), and implementing
nonpharmacological interventions (t= 5.113, p < .001).
Additional Results
In the pretest, participants were asked to identify the biggest challenge when
caring for an infant diagnosed with or displaying signs/symptoms of NAS. The responses
included having to care for other couplets or infants/not having enough time to
adequately care for all patients, parent compliance with plan of care, appropriately
managing signs and symptoms the infant is displaying, parent involvement, inconsistent
care among the care team, being nonjudgmental towards parents, inconsistent scoring
between nurses, determining level of severity, early recognition of signs/symptoms,
parent and healthcare professional education.
In the posttest, participants were asked to identify any new knowledge they had
gained from the educational presentation. The responses included learning new
information on signs/symptoms, medications, and nonpharmacological interventions,
frequency of Finnegan scoring tool, and healthcare costs due to neonatal abstinence
syndrome. The education also included bedside guides that could be utilized when caring
for infants diagnosed with NAS. Participant comments stated that the bedside guides
would be very useful for education and utilization when needed.
Summary
Data analysis was completed using IBM SPSS Statistics. Descriptive analysis was
utilized for quantitative and qualitative data interpretation. Prior to education, results of
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the pretest indicated that healthcare professionals would benefit from receiving further
education about neonatal abstinence syndrome and nonpharmacological interventions
when treating infants diagnosed with NAS. After the educational offering, participants
indicated their knowledge and confidence in caring for newborns with NAS and utilizing
nonpharmacological interventions as a treatment method had increased.
The purpose of this project was to increase the education provided to healthcare
professionals regarding neonatal abstinence syndrome and the nonpharmacological
interventions that should be utilized when caring for infants diagnosed with NAS.
Findings from this study indicate the need for increased neonatal abstinence syndrome
and nonpharmacological intervention education to healthcare professionals caring for
newborns in a hospital setting.
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CHAPTER V

Purpose

The purpose of this project was to increase the education provided to healthcare
professionals regarding neonatal abstinence syndrome (NAS) and the
nonpharmacological interventions that should be utilized when caring for infants
diagnosed with NAS. The study obtained data from healthcare professionals caring for
newborns in the hospital setting by utilization of a pretest and an identical posttest
without demographic questions. The pretest measured baseline participant knowledge and
confidence of neonatal abstinence syndrome and nonpharmacological interventions prior
to education being provided. The posttest measured participant knowledge and
confidence after the educational presentation. An identical six-week follow-up posttest
was optional for study participants; however, from the thirty study participants, only eight
participants indicated they would partake in the six-week follow up posttest, and only
five participants completed the six-week follow-up posttest. Therefore, the six-week
follow-up posttest results were disregarded.
Relationship of Outcomes to Research
Four research questions were examined for this project. Each question was
answered thoroughly and completely. The following research questions were examined.
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•

Prior to an educational offering, how frequently are healthcare
professionals caring for newborns in the hospital setting completing a
Finnegan Score on newborns born to women who tested positive for
substances known to cause NAS?

•

Prior to an educational offering on the nonpharmacological management
of NAS, which interventions are healthcare professionals caring for
newborns in the hospital setting implementing?

•

Will implementation of nonpharmacological intervention education
improve the knowledge of healthcare professionals caring for infants
diagnosed with NAS in the hospital setting?

•

Will implementation of nonpharmacological intervention education
improve the confidence of healthcare professionals caring for infants
diagnosed with NAS in the hospital setting?

The first question was examined by descriptive statistics percentages and
frequencies. Participants were asked to identify how often the participant cares for an
infant diagnosed with or displaying signs or symptoms of neonatal abstinence syndrome.
The participants were then asked to identify how frequently the Finnegan Neonatal
Abstinence Scoring System Tool is utilized when caring for an infant diagnosed with or
displaying signs or symptoms of neonatal abstinence syndrome. The participants had a
selection choice of every two hours, every three hours, every four hours, every six hours,
every eight hours, every twelve hours, as needed, or that a different scoring tool is
utilized. According to Cook & Fantasia (2019), “Finnegan scoring is started within 24
hours of birth and serial assessments are completed every 3 to 4 hours when the newborn
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is awake and fed. Neonates who do not require pharmacologic intervention should have
scoring completed for 4 consecutive days [and] neonates who require medication to treat
withdrawal symptoms are scored throughout treatment and for 48 to 72 hours after
medication is ceased” (p. 359). Participants who responded that a different scoring tool
was utilized were asked to identify the scoring tool. Of the participants (n=6) who
selected the option of utilization of a different scoring tool, all participants (n=6, 100%)
responded that the Eat, Sleep, Console (ESC) method is utilized. According to a study
conducted by Grossman, Lipshaw, Osborn, and Berkwitt (2018), “infants managed by
using the ESC approach were treated with morphine significantly less frequently than
they would have been by using the [Finnegan Scoring] approach. The ESC approach is an
effective method for the management of infants with NAS that limits pharmacologic
treatment and may lead to substantial reductions in length of stay.” Categorical data was
applied to find the frequency and percentages of each measure.
The second research question was examined by text analysis. Participants were
asked the open-ended question “what nonpharmacological interventions do you
implement when caring for an infant diagnosed with or displaying signs/symptoms of
NAS?” Participant responses were varied and some responses had similar
nonpharmacological interventions identified. Responses were examined and listed to gain
further insight into participants’ current practices. Examples of nonpharmacological
supportive care measures include gentle handling, on demand feedings, swaddling, dim
light, low noise, frequent feedings, utilizing high calorie formulas, holding, cuddling,
manual rocking, aromatherapy, massage therapy, skin-to-skin contact, pacifier use to
promote “self-soothing”, caregiver rooming-in, breastfeeding, and increasing
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parent/caregiver infant care (Allen et al., 2018, p. 1750; Artigas, 2014, p. 512; Cook &
Fantasia, 2019, p. 360; Jansson, 2020, p. 10-13; Kocherlakota, 2014, p. e553; MacVicar
& Kelly, 2019, p. 434-435).
The third research question was answered by comparing pretest and posttest
surveys. Participants were asked to rate current knowledge of neonatal abstinence
syndrome, Finnegan Neonatal Abstinence Syndrome Scoring Tool, and
nonpharmacological interventions for neonatal abstinence on a five-point Likert-type
scale, “very poor,” “poor,” “fair,” “good,” or “very good.” Each category was coded
using numerical data 1-5 starting at number one (very poor) to number five (very good).
The summative mean of the data collected for knowledge revealed an increase in
participant response by 0.59 points. The standard deviation increased when comparing
the pretest (0.81) and the posttest (0.85). These findings indicate that participants
perceived more knowledge of individual items after the educational presentation.
However, the standard deviation increase indicates greater variability on the posttest
versus the pretest. In a previous study conducted by Lucas and Knobel (2012),
knowledge of neonatal abstinence syndrome and the Finnegan Neonatal Abstinence
Syndrome Scoring Tool was increased when clinical practice guidelines and education
were introduced to neonatal intensive care unit (NICU) nurses working in a level three
NICU.
The fourth research question was answered by comparing pretest and posttest
surveys. Participants were asked to rate current confidence of caring for an infant
diagnosed with neonatal abstinence syndrome, recognizing signs/symptoms of neonatal
abstinence syndrome, utilizing the Finnegan Neonatal Abstinence Syndrome Scoring
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Tool, and implementing nonpharmacological interventions when caring for an infant
diagnosed with neonatal abstinence syndrome. Participants were asked to rate confidence
on a three-point Likert-type scale, “not confident,” “somewhat confident,” and
“completely confident.” Each category was coded using numerical data 1-3 starting at
number one (not confident) to number five (extremely confident).
The summative mean of the data collected for confidence revealed an increase in
participant response by 0.37 points. The standard deviation decreased when comparing
the pretest (0.61) and the posttest (0.46). These findings indicate participants perceived
greater confidence of individual items after the educational presentation. The standard
deviation was low, indicating less variability on the posttest compared to the pretest.
Observations
General observations noted during the project include poor completion rates.
Participants were recruited via convenience and snowball sampling via social media
platforms. The study had a total of forty-seven participants; however, only thirty
participants completed the full study. The study also had a six-week posttest option in
which only eight of the thirty participants indicated interest. Of the eight participants that
indicated interest in the six-week follow-up posttest, five participants responded.
The survey indicated increased knowledge and confidence in all measures. The
measure with the least increase on both knowledge and confidence involved “recognizing
signs and symptoms of NAS” and “utilizing the Finnegan NAS scoring tool.” The
measure with the greatest increase on both knowledge and confidence involved
implementing and utilizing nonpharmacological interventions in the treatment of NAS.
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This indicates all measures are being met, but curriculum involving signs and symptoms
and scoring tools should be re-evaluated for future educational designs.
Evaluation of Theoretical Framework
The data from this research supports Orlando’s Nursing Process Discipline
Theory of focusing on the patient’s needs. Orlando’s theory provides a framework for
identifying and addressing the immediate needs of the patient, resulting in positive
outcomes. This theory “focuses on the interaction between the [healthcare professional]
and patient, perception validation, and the use of the nursing process to produce positive
outcomes or patient improvement” (Petiprin, 2016, para. 9). Participants from this study
are seeking tools and resources to improve their knowledge and confidence when
utilizing nonpharmacological interventions when caring for infants diagnosed with or
displaying signs/symptoms of neonatal abstinence syndrome.
Evaluation of Logic Model
The logic model of this study identified the goal of this project, which was to
increase the knowledge of nonpharmacological interventions in the management of
neonatal abstinence syndrome by utilization of an educational presentation. The goal was
obtained by utilization of a pretest, educational presentation, and a posttest. The study
results show that education is beneficial for increasing knowledge and confidence
regarding neonatal abstinence syndrome and the utilization of nonpharmacological
interventions when caring for infants diagnosed with or displaying signs/symptoms of
neonatal abstinence syndrome.
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Limitations
The method chosen for the research participants was a one group pretest-posttest
design using descriptive statistics, mean, and standard deviation. One limitation in the
study included poor participation resulting in a sample size of thirty participants. The
project timeline of December 2020 through January 2021 may have contributed to the
smaller sample size. A larger timeline would be beneficial for a larger sample size.
Another limitation is the potential for participant bias due to the nature of the topic. There
was no sampling bias because participants were recruited by use of a convenience and
snowball sampling via social media platforms. A final limitation to the study is there is
no universal protocol for education and treatment of neonatal abstinence syndrome.
Therefore, education, knowledge, confidence, and tools vary significantly between
healthcare facilities. This was a small study with a convenience sample size of thirty and
therefore cannot be generalized. This study should be repeated with a larger sample
population for more accurate results.
Implications for Future Projects and Research
Evaluation of healthcare professionals’ knowledge and confidence regarding
neonatal abstinence syndrome and the utilization of nonpharmacological interventions in
the treatment of neonatal abstinence syndrome is a cost-effective method to obtain a
baseline for educational needs regarding the topic. The prevalence of maternal substance
abuse resulting in neonatal abstinence syndrome continues to increase at an alarming rate
in the United States. Between the years 2004 and 2010, the incidence of newborns
diagnosed with NAS increased fivefold, which has inevitably increased the number of
newborns requiring longer hospitalization and specialized care (Chiang et al., 2019, p.
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1193). Therefore, increased education for healthcare professionals regarding neonatal
abstinence syndrome should be utilized to provide better understanding and care to
infants diagnosed with NAS. This research could be replicated with additional
educational programs.
To improve the design for this project, the author could focus the education on
specific nursing units to better assess educational needs and improvement upon
completion of the project. The author could also utilize follow-up surveys at varying
intervals to assess for knowledge retention and utilization of education in practice.
Implications for Practice, Health Policy, and Education
The results of this study indicate there is a need for increased education regarding
neonatal abstinence syndrome and the utilization of nonpharmacological interventions in
the management of neonatal abstinence syndrome. Study outcomes were positive with a
posttest mean of (4.31) on knowledge and a posttest mean of (2.65) on confidence. These
results indicate that education is beneficial for improving knowledge and confidence
regarding neonatal abstinence syndrome and nonpharmacological interventions.
Recommendations to nursing practice could include the incorporation of neonatal
abstinence syndrome and nonpharmacological intervention education curricula on an
annual basis for healthcare professionals who care for newborns in a hospital setting.
Implementation of annual education could potentially increase overall knowledge and
confidence resulting in improved patient outcomes.
The results of this study and future studies can be utilized for healthcare
professionals to advocate for increased educational opportunities and funding regarding
neonatal abstinence syndrome. Legislative involvement could make education
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mandatory, provide better funding for educational opportunities, and provide continuity
between nursing units throughout the United States who care for infants diagnosed with
neonatal abstinence syndrome.
Summary
The purpose of this project was to increase healthcare professionals’ confidence,
knowledge of, and intent of utilizing nonpharmacological interventions in the treatment
of NAS. Through education, healthcare professionals caring for newborns in a hospital
setting will be better equipped and prepared to care for infants diagnosed with NAS,
which will ultimately improve patient care and outcomes. Nonpharmacological
interventions have been shown to reduce the length of hospitalizations, minimize
medication therapy, improve infant outcomes, and ultimately reduce healthcare
associated costs (Allen et al., 2018; Kocherlakota, 2014).
This project included a study utilizing a pretest, educational presentation, and a
posttest. The pretest indicated the need for increased education regarding neonatal
abstinence syndrome for healthcare professionals caring for infants in a hospital setting.
After the educational presentation, the posttest results indicated an increase in knowledge
and confidence levels of healthcare professionals regarding neonatal abstinence
syndrome and the utilization of nonpharmacological interventions when caring for infants
diagnosed with NAS. This study will hopefully encourage healthcare professionals to
partake in further educational opportunities to help improve knowledge of and confidence
in utilizing nonpharmacological interventions.
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APPENDIX

Appendix A
Pretest
For the following items, please select the letter by the answer that best represents
you (one per item).
1. Are you a healthcare provider that cares for newborns in the hospital setting?
A. Yes
B. No
2. What gender do you identify as?
A. Female
B. Male
C. Prefer not to answer
3. What is your current age?
A.
B.
C.
D.
E.
F.

Younger than 21 years old
21-30 years old
31-40 years old
41-50 years old
51-60 years old
61+ years old

4. What is your current role in caring for newborns?
A.
B.
C.
D.
E.
F.

Nurse Assistant
Nurse
Lactation Consultant
Advanced Practice Nurse
Physician Assistant
Physician

5. How long have you worked as a healthcare professional caring for newborns?
A.
B.
C.
D.

Less than 1 year
1-5 years
6-10 years
Greater than 10 years
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6. How frequently do you care for infants diagnosed with or showing signs and
symptoms of Neonatal Abstinence Syndrome?
A.
B.
C.
D.
E.

Less than 1 time a month
1-2 times a month
3-5 times a month
More than 5 times a month
I have never cared for an infant diagnosed with or showing symptoms
of NAS

7. How frequently do you utilize the Finnegan Neonatal Abstinence Syndrome
Scoring System when caring for an infant exposed to substance abuse while inutero?
A.
B.
C.
D.
E.
F.
G.
H.
I.

Never
Every 2 hours
Every 3 hours
Every 4 hours
Every 6 hours
Every 8 hours
Every 12 hours
As needed
My facility uses a different scoring tool (Please Specify)
____________

8. During the past year, have you participated in an educational program about
NAS?
A. Yes
B. No
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Neonatal Abstinence Syndrome Knowledge
Using the scale below, please select the number that best represents your knowledge of
NAS.
Very Poor = 1

Poor = 2

Fair = 3

Good = 4

Very Good = 5

How do you rate your current knowledge of:

9. Neonatal Abstinence Syndrome

1

2

3

4

5

10. Finnegan Neonatal Abstinence Syndrome Scoring System

1

2

3

4

5

11. Nonpharmacological Interventions for NAS

1

2

3

4

Using the scale below, please select the following number that best represents your
confidence level.
Not Confident = 1 Somewhat Confident = 2 Completely Confident = 3
How do you rate your current confidence with:

12. Caring for an infant diagnosed with NAS

1

2

3

13. Recognizing signs/symptoms of NAS

1

2

3

14. Utilizing the Finnegan NAS Scoring System

1

2

3

15. Implementing nonpharmacological interventions

1

2

3

16. What nonpharmacological interventions do you implement when caring for an
infant diagnosed with or displaying signs/symptoms of NAS? (Please answer
below)
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5

17. What do you find to be the biggest challenge when caring for an infant diagnosed
with or displaying signs/symptoms of NAS? (Please answer below)

18. Please provide additional comments.
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Appendix B
Posttest

Neonatal Abstinence Syndrome Knowledge
Using the scale below, please select the number that best represents your knowledge of
NAS.
Very Poor = 1

Poor = 2

Fair = 3

Good = 4

Very Good = 5

After viewing the educational offering, how do you rate your knowledge of:

1. Neonatal Abstinence Syndrome

1

2

3

4

5

2. Finnegan Neonatal Abstinence Syndrome Scoring System

1

2

3

4

5

3. Nonpharmacological Interventions for NAS

1

2

3

4

Using the scale below, please select the following number that best represents your
confidence level.
Not Confident = 1 Somewhat Confident = 2 Completely Confident = 3
After viewing the educational offering, how do you rate your confidence with:

4. Caring for an infant diagnosed with NAS

1

2

3

5. Recognizing signs/symptoms of NAS

1

2

3

6. Utilizing the Finnegan NAS Scoring System

1

2

3

7. Implementing nonpharmacological interventions

1

2

3
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5

8. What new knowledge have you learned after viewing the educational offering?

9. Please provide additional comments.

10. If you are willing to participate in a 6 week follow up survey, please provide your
email. The only use of your email address will be to send the 6-week follow-up
survey link.
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Appendix C
6 Week Posttest

Neonatal Abstinence Syndrome Knowledge
Using the scale below, please select the number that best represents your knowledge of
NAS.
Very Poor = 1

Poor = 2

Fair = 3

Good = 4

Very Good = 5

How do you rate your current knowledge of:

1. Neonatal Abstinence Syndrome

1

2

3

4

5

2. Finnegan Neonatal Abstinence Syndrome Scoring System

1

2

3

4

5

3. Nonpharmacological Interventions for NAS

1

2

3

4

Using the scale below, please select the following number that best represents your
confidence level.
Not Confident = 1 Somewhat Confident = 2 Completely Confident = 3
How do you rate your current confidence with:

4. Caring for an infant diagnosed with NAS

1

2

3

5. Recognizing signs/symptoms of NAS

1

2

3

6. Utilizing the Finnegan NAS Scoring System

1

2

3

7. Implementing nonpharmacological interventions

1

2

3
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5

8. What nonpharmacological interventions do you implement when caring for an
infant diagnosed with or displaying signs/symptoms of NAS? (Please answer
below)

9. What do you find to be the biggest challenge when caring for an infant diagnosed
with or displaying signs/symptoms of NAS? (Please answer below)

10. Has the educational guide for nonpharmacological interventions in the treatment
of infants with NAS changed how you provide care for these infants? If yes please
explain.

11. Please provide additional comments.
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Appendix D
Neonatal Abstinence Syndrome Bedside Tools

DRUG

ONSET OF
SYMPTOMS

DURATION
OF
SYMPTOMS

OPIOIDS
Heroin

24 hours- 2 days

8-10 days

Methadone

2-3 days

30 days or more

Buprenorphine (Subutex)

24 hours- 3 days

28 days or more

Prescription Opioids
(oxycodone/hydrocodone

24 hours – 4 days

10- 30 days

SSRIS (Celexa, Lexapro, Zoloft,
Paxil, Prozac)

24 hours- 2 days

2-6 days

Tricyclic Antidepressants (Elavil,
Sinequian, Vivactil, Pamelor,
Anafranil, Surmontil, Amoxapine)

24 hours – 2 days

2-6 days

Methamphetamines

24 hours

7-10 days

Inhalants/nicotine

24 hours – 2 days

2-7 days

Caffeine

24 hours- 2 days

1-7 days

NON-OPIOIDS
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Baby’s
Behavior
Prolonged
Crying

How You Can Help
•
•
•
•
•
•

Easily Upset or
Bothered

•

Hold baby skin to skin or swaddled in light blanket close to parent’s
body
Lower the lights and turn off loud noises
Use purposeful touch (stroking, or tickling can be irritating).
Hold baby swaddled in a “C” or fetal position with baby’s back to you
facing outward at a blank wall. Gently sway from side to side.
Hum and gently rock from side to side.
Watch for prolonged crying, which may cause baby to vomit.

•

Keep the room quiet and dim. Avoid loud music, TV/screen-time,
texting, phone calls, and conversations.
Try not to touch or wake the baby.
Swaddle baby in a light blanket, but help him stay contained with hands
close to his face.
Hold baby close to your body, and console him if he is upset.

Sleeplessness

•
•
•
•

Limit visitors and keep the room quiet.
Soft, gentle music and rocking may help.
Keep diaper area clean and dry. Use diaper cream to prevent diaper rash.
Feed baby when he’s hungry (small/frequent meals may be needed).

Difficult or Poor
Feeding

•

•
•

Excessive
Rooting or
Sucking

•
•
•
•

Feed small amounts often. If breastmilk supply is low, supplement with
formula to help infant feel satisfied.
Feed in a quiet, low-lit room with few distractions.
Focus on baby. Avoid being on the phone or having conversations while
baby eats
Offer a pacifier if baby has just eaten and still wants to suck
Keep baby’s hands clean. Do not use lotions or creams.
Keep baby swaddled and comforted
Offer a small meal

Spitting up or
Vomiting

•
•
•
•
•

Use a bulb syringe to clean out baby’s mouth
Change bedding and clothes to keep baby comfortable.
Burp baby often throughout feedings and offer rest breaks.
Offer smaller meals more often if large volumes cause vomiting
Respond to crying and offer comfort.

Sneezing, Stuffy
Nose, or
Breathing
Problems

•

Keep baby’s mouth and nose clean. Note any spit-up or mucus.
Stuffiness is often swelling/edema and cannot be suctioned.
Dress baby in light T-shirt or onesie and swaddle in a light blanket.
Feed baby slowly and offer rest breaks and burping with each feeding.
Always place baby on its back to sleep
If baby is awake hold him upright, fully supporting his head.

•
•

•
•
•
•
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Special Care Plan for: (Baby’s Name)
Breast
milk/Formula:

Diaper Care:

Supportive
Therapy:

Family Support
Team:

Common Symptoms
and Stress Cues
Infant Displays:

Effective Calming
Interventions:

Primary Nursing
Staff:
Social Work
Support/Plans:
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